Value Research Rating

4 star

Quality Score fund-quick-summary-circle

Quality Score8/10

Growth fund-quick-summary-circle

Growth6/10

Valuation Score fund-quick-summary-circle

Valuation Score2/10

Momentum Score fund-quick-summary-circle

Momentum Score10/10

Divi's Laboratories Ltd. Share Price

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range
Low: 5,866.10 High: 6,184.85
52 Week Range
Low: 3,350.00 High: 6,285.45
Liquidityliquidity High
Low Moderate High

Fundamentals

  • Market capMarket cap information

    ₹1,61,830 Cr

  • P/E RatioP/E Ratio information

    88.14

  • P/B RatioP/B Ratio information

    11.8

  • Industry P/EIndustry P/E information

    72.38

  • Debt to EquityDebt to Equity information

    0

  • ROEROE information

    12.15 %

  • ROCEROCE information

    16.46 %

  • Div. YieldDiv. Yield information

    0.49 %

  • Book ValueBook Value information

    513.62

  • EPSEPS information

    69

10 Years Aggregate

CFO

₹13,539.39 Cr

EBITDA

₹20,307.87 Cr

Net Profit

₹15,012.76 Cr

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Divi's Lab
56.16 3.29 19.61 60.51 8.62 27.50 21.66
BSE Sensex
13.19 3.79 -0.71 18.73 12.32 14.89 11.09
BSE Healthcare
41.19 1.57 2.54 45.56 20.99 26.85 11.39
As on 05-Dec-2024
2023
2022
2021
2020
2019
2018
2017
Divi's Lab
14.38 -27.04 21.54 111.23 25.10 34.90 40.15
BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91
BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Essential Checks View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials Detailed View

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios view all

loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...
P/E Ratio

--

--Min --Median --Max

loading...
P/B Ratio

--

--Min --Median --Max

loading...
Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer view all

Company
Price (₹) Market Cap (₹ Cr) P/E Ratio ROE
2,198.35 22,928.73 69.92 21.04
1,372.00 25,920.91 52.03 19.45
1,075.15 13,218.23 31.21 17.39
17,846.35 22,914.05 81.93 19.73

Shareholding Pattern Detailed Holdings

loading...

News & Analysis All News

About The Company More Details

Incorporated

1990

Chairman

Ramesh BV Nimmagadda

Managing Director

Murali K Divi

Group

Divis Labs

Headquarters

Hyderabad, Telangana
Edit peer-selector-edit
loading...
loading...
loading...
loading...

Quarterly Updates

Key Facts

  • Market cap market-cap-information ₹1,61,829.65 Cr
  • Revenue (TTM)revenue-information ₹8,614.00 Cr
  • Earnings (TTM) earning-information ₹1,836.00 Cr
  • Cash date-information ₹3,602.00 Cr
  • Total Debt info ₹0.00 Cr
  • Promoters' ownership promoters_ownership 51.89%
  • Liquidity liquidity High
  • 52 Week range week-range ₹3,350.00 - 6,285.45
  • Face value face-value ₹2.00
  • Shares outstanding share-outstanding 26,54,68,580
  • 10 Years Aggregate:

    CFO: ₹13,539.39 Cr

    EBITDA: ₹20,307.87 Cr

    Net Profit: ₹15,012.76 Cr

About The Company

  • Incorporated 1990
  • Chairman Ramesh BV Nimmagadda
  • Managing Director Murali K Divi
  • Group Divis Labs
  • Listing key-listing BSE: 532488, NSE: DIVISLAB
  • Country India
  • Headquarters headquarters Hyderabad, Telangana
  • Website website www.divislabs.com
  • Business

    Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom...  synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.  Read more

FAQs for Divi's Laboratories Ltd.

The total asset value of Divi's Laboratories Ltd stood at ₹ 15,467 Cr as on 30-Sep-24

The share price of Divi's Laboratories Ltd is ₹6,096.20 (NSE) and ₹6,096.00 (BSE) as of 05-Dec-2024 IST. Divi's Laboratories Ltd has given a return of 8.62% in the last 3 years.

Divi's Laboratories Ltd has a market capitalisation of ₹ 1,61,830 Cr as on 05-Dec-2024. As per Value Research classification, it is a Large Cap company.

The P/B ratio of Divi's Laboratories Ltd is 11.80 times as on 05-Dec-2024, a 177% premium to its peers’ median range of 4.26 times.

The P/E ratio of Divi's Laboratories Ltd is 88.14 times as on 05-Dec-2024, a 22% premium to its peers’ median range of 72.38 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Divi's Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Divi's Laboratories Ltd.

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

The prominent promoters of Divi's Laboratories Ltd. are

Name of promoters Holding percentage

NILIMA PRASAD DIVI

20.34%

SATCHANDRA KIRAN DIVI

20.34%

SWARNA LATHA DIVI

5.27%
Click here to see the full list

The chairman of the company is Ramesh BV Nimmagadda, and the managing director is Murali K Divi.

There is no promoter pledging in Divi's Laboratories Ltd.

Some of the close peers are:

Company Market Cap(₹ Cr)
25,839
22,336
21,281
13,405
Divi's Laboratories Ltd. Ratios
Return on equity(%)
13.55
Operating margin(%)
25.78
Net Margin(%)
20.9
Dividend yield(%)
0.49

Yes, TTM profit after tax of Divi's Laboratories Ltd was ₹1,836 Cr.